デフォルト表紙
市場調査レポート
商品コード
1619127

ラテラルフローアッセイ市場規模、シェア、成長分析、製品タイプ別、手法別、サンプルタイプ別、用途別、エンドユーザー別、地域別-産業別予測、2024~2031年

Lateral Flow Assays Market Size, Share, Growth Analysis, By Product (Kits & Reagents, Readers), By Technique (Sandwich assays, Competitive assays), By Sample Type, By Application, By End User, By Region - Industry Forecast 2024-2031


出版日
発行
SkyQuest
ページ情報
英文 242 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
ラテラルフローアッセイ市場規模、シェア、成長分析、製品タイプ別、手法別、サンプルタイプ別、用途別、エンドユーザー別、地域別-産業別予測、2024~2031年
出版日: 2024年12月18日
発行: SkyQuest
ページ情報: 英文 242 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ラテラルフローアッセイの世界市場規模は2022年に92億米ドルと評価され、2023年の99億1,000万米ドルから2031年には179億4,000万米ドルに成長し、予測期間中(2024~2031年)のCAGRは7.7%で成長する展望です。

ラテラルフローアッセイ(LFAs)またはイムノアッセイは、食品や水、飼料中の汚染物質、ヒトや動物の病原体やバイオマーカーなど、標的分析物の迅速な検出に不可欠なユーザーフレンドリーな診断ツールです。妊娠検査への応用で広く認知されているLFAは、感染症検査、薬剤誤用スクリーニング、迅速心臓マーカー診断にも対応しています。これらの検査は、水や電力、専門的なトレーニングを必要とせず、迅速で費用対効果の高い分析結果を記載しています。LFAは機能性を保証するために明確なテストラインとコントロールラインを備えており、リーダー技術と組み合わせれば定量が可能です。その柔軟性により、さまざまな環境でのポイントオブケア検査が可能となり、特に新興国市場における医療へのアクセスの課題に対処する上で極めて重要であり、市場開拓の原動力となっています。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次データと一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の展望
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と展望

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーター分析と影響
    • 競争企業間の敵対関係
    • 代替品の脅威
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 供給企業の交渉力

主要市場の考察

  • 重要成功要因
  • 競合の程度
  • 主要投資機会
  • 市場エコシステム
  • 市場の魅力指数(2023年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析
  • 技術の進歩
  • 規制情勢
  • 特許分析
  • ケーススタディ

ラテラルフローアッセイ市場規模:製品別&CAGR(2024~2031年)

  • 市場概要
  • キットと試薬
  • リーダー
    • デジタル/ハンドヘルドリーダー
    • ベンチトップリーダー

ラテラルフローアッセイ市場規模:技術別&CAGR(2024~2031年)

  • 市場概要
  • サンドイッチアッセイ
  • 競合アッセイ
  • マルチプレックス検出アッセイ

ラテラルフローアッセイ市場規模:サンプルタイプ別&CAGR(2024~2031年)

  • 市場概要
  • 血液サンプル
  • 尿サンプル
  • 唾液サンプル
  • その他のサンプル

ラテラルフローアッセイ市場規模:用途別&CAGR(2024~2031年)

  • 市場概要
  • 臨床検査
    • 感染症検査
    • 心臓マーカー検査
    • 妊娠と不妊検査
    • コレステロール/脂質検査
    • 薬剤乱用検査
    • その他の臨床検査
  • 獣医診断
  • 食品安全と環境検査
  • 医薬品開発と品質検査

ラテラルフローアッセイ市場規模:エンドユーザー別&CAGR(2024~2031年)

  • 市場概要
  • 病院・クリニック
  • 在宅ケア
  • 診断ラボ
  • 製薬・バイオテクノロジー企業
  • その他

ラテラルフローアッセイ市場規模&CAGR(2024~2031年)

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • スペイン
    • フランス
    • イタリア
    • その他の欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他のアジア太平洋
  • ラテンアメリカ
    • ブラジル
    • その他のラテンアメリカ
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他の中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2023年)
  • 主要市場企業が採用した戦略
  • 市場の最近の動向
  • 企業の市場シェア分析(2023年)
  • 主要企業の企業プロファイル
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較(2021~2023年)

主要企業プロファイル

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • QuidelOrtho Corporation
  • Danaher Corporation
  • Siemens AG
  • Becton, Dickinson and Company
  • Biomerieux SA
  • Thermo Fisher Scientific Inc.
  • PerkinElmer Inc.
  • Qiagen N.V.
  • Merck KGaA
  • Hologic, Inc.
  • Abcam plc
  • Surmodics Inc.
  • Chembio Diagnostics, Inc.(Biosynex)
  • Orasure Technologies
  • DCN Diagnostics
  • Polysciences Inc.
  • Abingdon Health
  • Oranoxis Inc.
  • Aesku.Group GmbH
  • Bio Group Medical System S.R.L

結論と推奨事項

目次
Product Code: SQMIG35A2696

Global Lateral Flow Assays Market size was valued at USD 9.2 billion in 2022 and is poised to grow from USD 9.91 billion in 2023 to USD 17.94 billion by 2031, growing at a CAGR of 7.7% during the forecast period (2024-2031).

Lateral flow assays (LFAs), or immunoassays, are user-friendly diagnostic tools essential for rapid detection of target analytes, including contaminants in food, water, and animal feed, as well as pathogens and biomarkers in humans and animals. Widely recognized for their applications in pregnancy tests, LFAs also cater to infectious disease testing, drug misuse screening, and rapid cardiac marker diagnostics. These tests operate without the need for water, power, or specialized training, offering quick and cost-effective analytical results. LFAs feature clear test and control lines for functionality assurance and can be quantitative when paired with reader technology. Their flexibility enables point-of-care testing across various environments, making them pivotal in addressing healthcare accessibility challenges, particularly in developing regions, thus driving market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Lateral Flow Assays market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Lateral Flow Assays Market Segmental Analysis

Global Lateral Flow Assays Market is segmented by Product, Technique, Sample Type, Application, End User, and region. Based on Product, the market is segmented into Kits & Reagents, Readers. Based on Technique, the market is segmented into Sandwich assays, Competitive assays, Multiplex detection assays. Based on Sample Type, the market is segmented into Blood samples, Urine samples, Saliva samples, and Other samples. Based on Application, the market is segmented into Clinical Testing, Veterinary Diagnostics, Food Safety & Environment Testing, Drug Development & Quality Testing. Based on End User, the market is segmented into Hospitals & clinics, Home care settings, Diagnostic laboratories, Pharmaceutical & biotechnology companies, and Other end users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Lateral Flow Assays Market

A significant factor driving the growth of the global lateral flow assays market is the increasing adoption of lateral flow devices in home healthcare settings. Their user-friendly nature, portability, and ability to deliver rapid results without requiring additional equipment or medical expertise have led to a surge in the use of these devices since their inception. Additionally, the fact that these tests can be obtained without a prescription is further enhancing their popularity and supporting market growth. Other contributing elements include the presence of reimbursement organizations, funding initiatives, collaborations between major pharmaceutical companies, and ongoing technological advancements, all of which are expected to elevate the demand for lateral flow rapid diagnostic tests.

Restraints in the Global Lateral Flow Assays Market

The growth of the global lateral flow assays market is hindered by several key constraints. One significant issue is the relatively low precision of results produced by lateral flow tests compared to laboratory testing, which medical professionals often prefer due to its higher accuracy. Additionally, the high costs associated with lateral flow assays pose a substantial barrier to market proliferation, particularly in low-income regions. In such areas, limited awareness and a shortage of skilled professionals further exacerbate these challenges, restricting the widespread adoption and acceptance of lateral flow tests and ultimately inhibiting market expansion.

Market Trends of the Global Lateral Flow Assays Market

The Global Lateral Flow Assays market is witnessing remarkable growth driven by the increasing demand for rapid and reliable testing methods across various sectors, particularly in food quality monitoring. As food safety regulations become more stringent due to rising public health concerns over contamination risks from toxins, heavy metals, and adulterants, the adoption of lateral flow assays as "quick tests" is on the rise. Their ability to deliver rapid, single-use results enhances efficiency in detecting contaminants and residues in food products, beverages, and dairy. This trend is further supported by the growing analytical community's preference for simple and cost-effective detection methodologies, positioning lateral flow assays as a pivotal tool in ensuring food safety and quality worldwide.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Driver & Opportunities
    • Restraints & Challenges
  • Porters Analysis & Impact
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2023
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Technological Advancement
  • Regulatory Landscape
  • Patent Analysis
  • Case Studies

Global Lateral Flow Assays Market Size by Product & CAGR (2024-2031)

  • Market Overview
  • Kits & Reagents
  • Readers
    • Digital/Handheld Readers
    • Benchtop Readers

Global Lateral Flow Assays Market Size by Technique & CAGR (2024-2031)

  • Market Overview
  • Sandwich assays
  • Competitive assays
  • Multiplex detection assays

Global Lateral Flow Assays Market Size by Sample Type & CAGR (2024-2031)

  • Market Overview
  • Blood samples
  • Urine samples
  • Saliva samples
  • Other samples

Global Lateral Flow Assays Market Size by Application & CAGR (2024-2031)

  • Market Overview
  • Clinical Testing
    • Infectious Disease Testing
    • Cardiac Marker Testing
    • Pregnancy & Fertility Testing
    • Cholesterol/Lipid Testing
    • Drugs-of-abuse Testing
    • Other Clinical Tests
  • Veterinary Diagnostics
  • Food Safety & Environment Testing
  • Drug Development & Quality Testing

Global Lateral Flow Assays Market Size by End User & CAGR (2024-2031)

  • Market Overview
  • Hospitals & clinics
  • Home care settings
  • Diagnostic laboratories
  • Pharmaceutical & biotechnology companies
  • Other end users

Global Lateral Flow Assays Market Size & CAGR (2024-2031)

  • North America (Product, Technique, Sample Type, Application, End User)
    • US
    • Canada
  • Europe (Product, Technique, Sample Type, Application, End User)
    • UK
    • Germany
    • Spain
    • France
    • Italy
    • Rest of Europe
  • Asia-Pacific (Product, Technique, Sample Type, Application, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America (Product, Technique, Sample Type, Application, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product, Technique, Sample Type, Application, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2023
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Abbott Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • F. Hoffmann-La Roche Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • QuidelOrtho Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson and Company
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biomerieux SA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PerkinElmer Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Qiagen N.V.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hologic, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abcam plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Surmodics Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Chembio Diagnostics, Inc. (Biosynex)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Orasure Technologies
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DCN Diagnostics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Polysciences Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abingdon Health
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Oranoxis Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Aesku.Group GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio Group Medical System S.R.L
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendation